


Biotech’s AI Race Is No Longer About Models. It’s About Infrastructure.
Roche’s latest Nvidia build is not just another AI headline.

Abu Dhabi Wants to Own Longevity Biotech—and Juvenescence Is the Test Case
Abu Dhabi’s push to become a global life-sciences hub has

Beijing’s Biotech Blitz Is Outpacing America. Washington Needs a War Plan.
For decades, the United States has led the world in

Breaking the Bias: How Precision Medicine Can Overcome Ancestral Disparities
In the rapidly advancing field of precision medicine, where treatments

Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate
Illumina, a prominent biotech firm specializing in gene-sequencing technology, is

































